297 related articles for article (PubMed ID: 12691384)
1. Neuroprotective effects of GYKI 52466 on experimental spinal cord injury in rats.
Colak A; Soy O; Uzun H; Aslan O; Barut S; Belce A; Akyildiz A; Taşyürekli M
J Neurosurg; 2003 Apr; 98(3 Suppl):275-81. PubMed ID: 12691384
[TBL] [Abstract][Full Text] [Related]
2. Time-level relationship for nitric oxide and the protective effects of aminoguanidine in experimental spinal cord injury.
Soy O; Aslan O; Uzun H; Barut S; Iğdem AA; Belce A; Colak A
Acta Neurochir (Wien); 2004 Dec; 146(12):1329-35; discussion 1335-6. PubMed ID: 15309585
[TBL] [Abstract][Full Text] [Related]
3. The neuroprotective effects of z-DEVD.fmk, a caspase-3 inhibitor, on traumatic spinal cord injury in rats.
Barut S; Unlü YA; Karaoğlan A; Tunçdemir M; Dağistanli FK; Oztürk M; Colak A
Surg Neurol; 2005 Sep; 64(3):213-20; discussion 220. PubMed ID: 16099247
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection and functional recovery after application of the caspase-9 inhibitor z-LEHD-fmk in a rat model of traumatic spinal cord injury.
Colak A; Karaoğlan A; Barut S; Köktürk S; Akyildiz AI; Taşyürekli M
J Neurosurg Spine; 2005 Mar; 2(3):327-34. PubMed ID: 15796358
[TBL] [Abstract][Full Text] [Related]
5. Calpain inhibitor AK 295 inhibits calpain-induced apoptosis and improves neurologic function after traumatic spinal cord injury in rats.
Colak A; Kaya M; Karaoğlan A; Sağmanligil A; Akdemir O; Sahan E; Celik O
Neurocirugia (Astur); 2009 Jun; 20(3):245-54. PubMed ID: 19575128
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of melatonin and methylprednisolone in experimental spinal cord injury.
Kaptanoglu E; Tuncel M; Palaoglu S; Konan A; Demirpençe E; Kilinç K
J Neurosurg; 2000 Jul; 93(1 Suppl):77-84. PubMed ID: 10879762
[TBL] [Abstract][Full Text] [Related]
7. Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury.
Cayli SR; Kocak A; Yilmaz U; Tekiner A; Erbil M; Ozturk C; Batcioglu K; Yologlu S
Eur Spine J; 2004 Dec; 13(8):724-32. PubMed ID: 15232723
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the dose-dependent neuroprotective effects of agmatine in experimental spinal cord injury: a prospective randomized and placebo-control trial.
Kotil K; Kuscuoglu U; Kirali M; Uzun H; Akçetin M; Bilge T
J Neurosurg Spine; 2006 May; 4(5):392-9. PubMed ID: 16703907
[TBL] [Abstract][Full Text] [Related]
9. Minocycline treatment inhibits lipid peroxidation, preserves spinal cord ultrastructure, and improves functional outcome after traumatic spinal cord injury in the rat.
Sonmez E; Kabatas S; Ozen O; Karabay G; Turkoglu S; Ogus E; Yilmaz C; Caner H; Altinors N
Spine (Phila Pa 1976); 2013 Jul; 38(15):1253-9. PubMed ID: 23370685
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of Ac.YVAD.cmk on experimental spinal cord injury in rats.
Karaoğlan A; Kaya E; Akdemir O; Sağmanligil A; Bilguvar K; Cirakoğlu B; Sahan E; Erdoğan N; Barut AE; Colak A
Surg Neurol; 2008 Jun; 69(6):561-7. PubMed ID: 18262241
[TBL] [Abstract][Full Text] [Related]
11. Effects of GYKI 52466 on early vasospasm in rats.
Colak A; Soy O; Karaoglan A; Akdemir O; Kokturk S; Sagmanligil A; Tasyurekli M
Cent Eur Neurosurg; 2009 Nov; 70(4):187-94. PubMed ID: 19851958
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects and impact on caspase-12 expression of tauroursodeoxycholic acid after acute spinal cord injury in rats.
Dong Y; Miao L; Hei L; Lin L; Ding H
Int J Clin Exp Pathol; 2015; 8(12):15871-8. PubMed ID: 26884858
[TBL] [Abstract][Full Text] [Related]
13. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma.
Wrathall JR; Teng YD; Marriott R
Exp Neurol; 1997 Jun; 145(2 Pt 1):565-73. PubMed ID: 9217092
[TBL] [Abstract][Full Text] [Related]
14. Q-VD-OPh, a pancaspase inhibitor, reduces trauma-induced apoptosis and improves the recovery of hind-limb function in rats after spinal cord injury.
Colak A; Antar V; Karaoğlan A; Akdemir O; Sahan E; Celik O; Sağmanligil A
Neurocirugia (Astur); 2009 Dec; 20(6):533-40; discussion 540. PubMed ID: 19967318
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent neuroprotective effects of melatonin on experimental spinal cord injury in rats.
Gül S; Celik SE; Kalayci M; Taşyürekli M; Cokar N; Bilge T
Surg Neurol; 2005 Oct; 64(4):355-61. PubMed ID: 16231427
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructure protection and attenuation of lipid peroxidation after blockade of presynaptic release of glutamate by lamotrigine in experimental spinal cord injury.
Tufan K; Oztanir N; Ofluoglu E; Ozogul C; Uzum N; Dursun A; Pasaoglu H; Pasaoglu A
Neurosurg Focus; 2008; 25(5):E6. PubMed ID: 18980480
[TBL] [Abstract][Full Text] [Related]
17. Effect of mexiletine on lipid peroxidation and early ultrastructural findings in experimental spinal cord injury.
Kaptanoglu E; Caner HH; Sürücü HS; Akbiyik F
J Neurosurg; 1999 Oct; 91(2 Suppl):200-4. PubMed ID: 10505505
[TBL] [Abstract][Full Text] [Related]
18. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury.
Erşahin M; Çevik Ö; Akakın D; Şener A; Özbay L; Yegen BC; Şener G
Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):131-9. PubMed ID: 22986158
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of raloxifene on experimental spinal cord injury in rats.
Ismailoğlu Ö; Oral B; Sütcü R; Kara Y; Tomruk O; Demir N
Am J Med Sci; 2013 Jan; 345(1):39-44. PubMed ID: 23221506
[TBL] [Abstract][Full Text] [Related]
20. Tauroursodeoxycholic acid and secondary damage after spinal cord injury in rats.
Colak A; Kelten B; Sağmanligil A; Akdemir O; Karaoğlan A; Sahan E; Celik O; Barut S
J Clin Neurosci; 2008 Jun; 15(6):665-71. PubMed ID: 18343118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
